Report Detail

Other Global Seasonal Affective Disorder Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3737095
  • |
  • 10 September, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.

Scope of the Report:
The global Seasonal Affective Disorder Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Seasonal Affective Disorder Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Seasonal Affective Disorder Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Seasonal Affective Disorder Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Allergan
Pfizer
Roche
Eli Lily
GlaxoSmithKline
Teva Pharmaceuticals
Bausch Health Companies
Mylan
Sanofi
Novartis
Johnson & Johnson
Koninklijke Philips
Beurer GmbH
Lucimed (Luminette)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Light Therapy (Phototherapy)
Medication
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others


Table of Contents

    1 Seasonal Affective Disorder Therapeutics Market Overview

    • 1.1 Product Overview and Scope of Seasonal Affective Disorder Therapeutics
    • 1.2 Classification of Seasonal Affective Disorder Therapeutics by Types
      • 1.2.1 Global Seasonal Affective Disorder Therapeutics Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Types in 2018
      • 1.2.3 Light Therapy (Phototherapy)
      • 1.2.4 Medication
      • 1.2.5 Others
    • 1.3 Global Seasonal Affective Disorder Therapeutics Market by Application
      • 1.3.1 Global Seasonal Affective Disorder Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospitals
      • 1.3.3 Clinics
      • 1.3.4 Others
    • 1.4 Global Seasonal Affective Disorder Therapeutics Market by Regions
      • 1.4.1 Global Seasonal Affective Disorder Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Seasonal Affective Disorder Therapeutics (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Allergan
      • 2.1.1 Business Overview
      • 2.1.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Allergan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Pfizer
      • 2.2.1 Business Overview
      • 2.2.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Pfizer Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Roche
      • 2.3.1 Business Overview
      • 2.3.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Roche Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Eli Lily
      • 2.4.1 Business Overview
      • 2.4.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 GlaxoSmithKline
      • 2.5.1 Business Overview
      • 2.5.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Teva Pharmaceuticals
      • 2.6.1 Business Overview
      • 2.6.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Bausch Health Companies
      • 2.7.1 Business Overview
      • 2.7.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Mylan
      • 2.8.1 Business Overview
      • 2.8.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Mylan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Sanofi
      • 2.9.1 Business Overview
      • 2.9.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Sanofi Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Novartis
      • 2.10.1 Business Overview
      • 2.10.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Novartis Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Johnson & Johnson
      • 2.11.1 Business Overview
      • 2.11.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Johnson & Johnson Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Koninklijke Philips
      • 2.12.1 Business Overview
      • 2.12.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Koninklijke Philips Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Beurer GmbH
      • 2.13.1 Business Overview
      • 2.13.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Beurer GmbH Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Lucimed (Luminette)
      • 2.14.1 Business Overview
      • 2.14.2 Seasonal Affective Disorder Therapeutics Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Seasonal Affective Disorder Therapeutics Market Competition, by Players

    • 3.1 Global Seasonal Affective Disorder Therapeutics Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Seasonal Affective Disorder Therapeutics Players Market Share
      • 3.2.2 Top 10 Seasonal Affective Disorder Therapeutics Players Market Share
    • 3.3 Market Competition Trend

    4 Global Seasonal Affective Disorder Therapeutics Market Size by Regions

    • 4.1 Global Seasonal Affective Disorder Therapeutics Revenue and Market Share by Regions
    • 4.2 North America Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.5 South America Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)

    5 North America Seasonal Affective Disorder Therapeutics Revenue by Countries

    • 5.1 North America Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
    • 5.2 USA Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)

    6 Europe Seasonal Affective Disorder Therapeutics Revenue by Countries

    • 6.1 Europe Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
    • 6.2 Germany Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.3 UK Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.4 France Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue by Countries

    • 7.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
    • 7.2 China Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.5 India Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)

    8 South America Seasonal Affective Disorder Therapeutics Revenue by Countries

    • 8.1 South America Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
    • 8.2 Brazil Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Seasonal Affective Disorder Therapeutics by Countries

    • 9.1 Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)

    10 Global Seasonal Affective Disorder Therapeutics Market Segment by Type

    • 10.1 Global Seasonal Affective Disorder Therapeutics Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Seasonal Affective Disorder Therapeutics Market Forecast by Type (2019-2024)
    • 10.3 Light Therapy (Phototherapy) Revenue Growth Rate (2014-2024)
    • 10.4 Medication Revenue Growth Rate (2014-2024)
    • 10.5 Others Revenue Growth Rate (2014-2024)

    11 Global Seasonal Affective Disorder Therapeutics Market Segment by Application

    • 11.1 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Application (2014-2019)
    • 11.2 Seasonal Affective Disorder Therapeutics Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2014-2019)
    • 11.4 Clinics Revenue Growth (2014-2019)
    • 11.5 Others Revenue Growth (2014-2019)

    12 Global Seasonal Affective Disorder Therapeutics Market Size Forecast (2019-2024)

    • 12.1 Global Seasonal Affective Disorder Therapeutics Market Size Forecast (2019-2024)
    • 12.2 Global Seasonal Affective Disorder Therapeutics Market Forecast by Regions (2019-2024)
    • 12.3 North America Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
    • 12.4 Europe Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
    • 12.6 South America Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Seasonal Affective Disorder Therapeutics. Industry analysis & Market Report on Seasonal Affective Disorder Therapeutics is a syndicated market report, published as Global Seasonal Affective Disorder Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Seasonal Affective Disorder Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,818.80
      4,228.20
      5,637.60
      3,267.72
      4,901.58
      6,535.44
      538,564.80
      807,847.20
      1,077,129.60
      290,232.00
      435,348.00
      580,464.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report